Evidence map›Paper›PMID 24040011›Full record

ArticlePloS one2013

Muricholic acids inhibit Clostridium difficile spore germination and growth.

Michael B Francis, Charlotte A Allen, Joseph A Sorg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 67 citations in OpenAlex.

  1. Journal of Taibah University Medical Sciences · 2026
    Article
  2. Article
  3. Article
  4. A multifunctional probiotic co-delivery platform for the treatment of Clostridium difficile infection.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  5. Article
  6. Unravelling three-way interactions betweenJournal of medical microbiology · 2025
    Review
  7. Review
  8. Review
  9. Repurposing dried blood spot device technology to examine bile acid profiles in human dried fecal spot samples.American journal of physiology. Gastrointestinal and liver physiology · 2024
    Article
  10. Review
  11. Review
  12. Article
  13. Effects of Hyperbaric Oxygen Therapy forJournal of the anus, rectum and colon · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Frontiers in microbiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael B FrancisDepartment of Biology, Texas A&M University, College Station, Texas, United States of America.
Charlotte A Allen
Joseph A Sorg
Texas A&M University · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

Infections caused by Clostridium difficile have increased steadily over the past several years. While studies on C. difficile virulence and physiology have been hindered, in the past, by lack of genetic approaches and suitable animal models, newly developed technologies and animal models allow these processes to be studied in detail. One such advance is the generation of a mouse-model of C. difficile infection. The development of this system is a major step forward in analyzing the genetic requirements for colonization and infection. While important, it is equally as important in understanding what differences exist between mice and humans. One of these differences is the natural bile acid composition. Bile acid-mediated spore germination is an important step in C. difficile colonization. Mice produce several different bile acids that are not found in humans. These muricholic acids have the potential to impact C. difficile spore germination. Here we find that the three muricholic acids (α-muricholic acid, β-muricholic acid and ω-muricholic acid) inhibit C. difficile spore germination and can impact the growth of vegetative cells. These results highlight an important difference between humans and mice and may have an impact on C. difficile virulence in the mouse-model of C. difficile infection.

Indexed as

AnimalsCholic AcidsClostridioides difficileEnterocolitis, PseudomembranousHumansKineticsMiceMicrobial Sensitivity TestsMicrobial ViabilityMolecular StructureSpecies SpecificitySpores, BacterialCholic Acidsmuricholic acid

Identifiers

PMID24040011
PMCPMC3767737
OpenAlexW1974402925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.